Molecular Magnetic Resonance Imaging of Aneurysmal Inflammation Using a Redox Active Iron Complex., PMID:36822678
Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron., PMID:36851745
Can Immune Therapy Cure Acute Myeloid Leukemia?, PMID:36949279
Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2., PMID:36961450
A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy., PMID:37090184
Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer., PMID:37158852
Cognitive function in UK adults seropositive for Helicobacter pylori., PMID:37285350
Expression of Envelope Protein Encoded by Endogenous Retrovirus K102 in Rheumatoid Arthritis Neutrophils., PMID:37317284
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy., PMID:37337107
Rapid Antigen and Antibody Microfluidic Immunofluorescence Assays Compared to Culture, PCR, and Laboratory Reference Tests: Performance in a Longitudinal Cohort., PMID:37353225
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina., PMID:37383986
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia., PMID:37393401
Enhanced Photoluminescence Detection of Immunocomplex Formation by Antibody-Functionalized, Ge-Doped Biosilica from the Diatom Cyclotella sp., PMID:37446467
Role of procalcitonin in predicting complications of Kawasaki disease., PMID:37524408
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorism., PMID:37594915
Germline-encoded specificities and the predictability of the B cell response., PMID:37624867
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial., PMID:37640860
Intravitreal injections with a low consumption technique have a low infection rate., PMID:37758841
Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial)., PMID:37776074
Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2., PMID:37853106
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease., PMID:37966285
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines., PMID:38215338
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial., PMID:38272046
Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies., PMID:38327783
Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome., PMID:38355030
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2., PMID:38382813
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adults., PMID:38437908
Helicobacter pylori, persistent infection burden and structural brain imaging markers., PMID:38529358
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective., PMID:38555401
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease., PMID:38692303
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial., PMID:38798684
A hybrid demultiplexing strategy that improves performance and robustness of cell hashing., PMID:38828640
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC., PMID:39003185
Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial., PMID:39041887
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial., PMID:39325506
Multiomics Reveals a Mechanism: Glycogen Synthesis, Galactose Metabolism, and Ethanol Degradation Pathways, the Durable Role of Neutralizing Antibodies in Preventing COVID-19., PMID:39464477
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions., PMID:39527587
Strategies following failure of CAR-T-cell therapy in non-Hodgkin lymphoma., PMID:39533016
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management., PMID:39674687
2024 Update of the RECOVER-Adult Long COVID Research Index., PMID:39693079
Analyses of biosynthesis mutants reveal that the fifth and sixth sugars of the Porphyromonas gingivalis O-glycan are L-fucose and N-acetylgalactosamine respectively., PMID:39701196
Sex Differences in Long COVID., PMID:39841477
Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses., PMID:39937896
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants., PMID:40116505
Combination immunotherapy induces post-intervention control of HIV., PMID:40166020
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution., PMID:40195984
Real-world use of complement inhibitors for haemolytic uraemic syndrome: an analysis of the European Rare Kidney Disease Registry cohort., PMID:40224677
Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia., PMID:40359013
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial., PMID:40383127
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution., PMID:40463375
For research use only. Not for human or drug use.
